MedPath

Excess Opioid Disposal Following Orthopedic Foot and Ankle Surgery

Not Applicable
Completed
Conditions
Medication Disposal
Behavior
Interventions
Device: Deterra Drug Deactivation System
Registration Number
NCT03285061
Lead Sponsor
Brigham and Women's Hospital
Brief Summary

This study aims to survey the drug disposal methods of orthopedic foot and ankle patients with excess pain medication following and operation. The study is a randomized control trial comparing the use of FDA approved at home disposal methods to current clinical methods of recommending disposal at medication drop off locations.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • This study will include foot and ankle orthopedic patients at Brigham and Women's Hospital undergoing a surgical procedure.
Exclusion Criteria
  • Those under age 18 will be excluded from this study, as their variation in care could affect the data. We will also exclude adults with impaired decision-making capacity and adults who take methadone or have a history of prior opioid dependence.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
At Home DisposalDeterra Drug Deactivation SystemWith patients' prescription for post operative pain medication, a Deterra portable drug deactivation system will be provided, along with instructions on proper use. They will be asked complete a survey at their 6 post operative follow-up on excess medication disposal.
Primary Outcome Measures
NameTimeMethod
Number of Participants Who Safely Disposed The Excess Medication6 weeks

Patients will be given a survey to obtain their method of disposal for excess post-operative pain medication.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath